Director, Value & Evidence Strategy

Develop and implement comprehensive HEOR strategic evaluations of pipeline programs, including unmet needs assessments, from a payer perspective. Design, implement, and oversee economic models, real-world evidence (RWE) studies to support the value story, and patient-reported outcome (PRO) assessments. Collaborate cross-functionally with internal stakeholders, including clinical development, regulatory, medical affairs, and commercial teams, to integrate HEOR insights into the clinical development plans. Engage with external stakeholders, including payers, key opinion leaders (KOLs), and patient advocacy groups, to understand evidence requirements and optimize data generation strategies. Collaborate cross-functionally to develop key value messages and an integrated evidence plan that aligns with market access, medical, and commercial strategies. Stay abreast of evolving HEOR methodologies, regulatory requirements, and market access landscapes specific to neurology and other indications. Engage with key opinion leaders, academic institutions, and industry partners to support study design, execution, and dissemination of HEOR studies. Lead the development of value dossiers (GVD, AMCP) and health technology assessment (HTA) submissions to support reimbursement and market access efforts globally. Doctoral degree (PhD, DrPH, ScD) in health services research, epidemiology, health economics, or related field with 7+ years professional experience in study design, research methodology, and statistical analysis in a pharmaceutical/biotech, consulting, healthcare, academic or research setting Master's degree with 10+ years professional experience in study design, research methodology, and statistical analysis in a pharmaceutical/biotech, consulting, healthcare, academic or research setting Familiarity with neurology disease areas such as Alzheimer's disease, Parkinson's disease, or rare neurological disorders is a plus. Excellent communication and presentation skills, both written and oral Extensive knowledge of the global regulatory, HTA and P&R landscape, as well as understanding of other development-related functions as they relate to all phases of drug development. Experience leading complex products and early phase HEOR strategy in support of pipeline development. Excellent analytical, strategic, and project management skills. Publication track record in peer-reviewed journals and conference presentations. Strong understanding of HEOR methodologies, including economic modeling, RWE generation, and PRO development. Ability to work independently and collaboratively with multidisciplinary groups